Biopsy Devices : Technology and Global Markets - ABC6 - Providence, RI and New Bedford, MA News, Weather

Biopsy Devices : Technology and Global Markets

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Biopsy Devices : Technology and Global Markets

https://www.reportbuyer.com/product/2212013/Biopsy-Devices--Technology-and-Global-Markets.html

This report provides an in-depth study of the global biopsy devices methods by device, therapautic segments and geographic markets from 2012 through 2018, with five-year CAGR projections from 2013 through 2018. It focuses on vital display technologies used in biopsy such as ultrasound, magnetic resonance, computing tomography, among others. In addition, it also includes analysis of key devices such as breast biopsy devices, core needle biopsy devices, fine needles, gastro intestinal biopsy devices, robotic guidance systems technologies and non-thermal ablation techniques. Information on the market by trends and estimates of key therapeutic areas like breast cancer, lung cancer, and cervical cancer, among others, have been reviewed in detail.

Use this report to:
- Assess the dynamics that have significant impact on the growth of the biopsy devices market.
- Estimate the biopsy devices market and its sub segments from 2013 through 2018 by procedures and by geographical locations.
- Thoroughly analyze the market trends and technology assessments.
- Receive information on key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance
systems technologies involved in thermal ablation techniques and non–thermal ablation techniques.

Highlights
- The global market for biopsy devices reached $1.4 billion in 2013. This market is further expected to grow to $1.5 billion in 2014 and $1.9 billion in 2018, a compound annual growth rate (CAGR) of 6.3% over the five year period 2013 to 2018.
- The North American market reached $612.1 million in 2013. This market is expected to grow to $643.6 million in 2014 and $767.8 million in 2018, with a CAGR of 4.6% over the five year period 2013 to 2018.
- The European market reached $522.9 million in 2013. This market is expected to grow to $557.7 million in 2014 and $680.0 million in 2018, a CAGR of 5.4% over the five year period 2013 to 2018.

INTRODUCTION

STUDY AND OBJECTIVE
The objective of this report is to:
- Assess the dynamics that have significant impact on the growth of the biopsy devices market.
- Estimate the biopsy devices market and its sub segments from 2013 through 2018 by procedures and by geographical locations.
- Analyze the key strategies, competitive insights and development of key companies in the market.
- Provide segmented analysis based on devices, therapeutic segments and geographical locations.
- Thoroughly analyze the market trends and technology assessments.
- Study intensively the challenges that must be addressed and opportunities that can be leveraged by market participants.

STUDY BACKGROUND
The key criterion for successful cancer treatment is early diagnosis of the disease. However, in the past, it was extremely difficult for doctors to recommend biopsy to patients that were considered low–risk (less probability of positive cancer test, howevermay need biopsy for confirmation) because a conventional biopsy methods involved complex technical issues along with increased trauma and stress among the patients. However, with the increased adoption of non–invasive methods, the process is now being recommended for low–risk patients as well. This also reduces the stress levels and recovery period of the patients. There are significant novel cancer diagnostic and biopsy methods that are introduced and are evidencing significant growth rate due to increased awareness among the patients. The report discusses key innovations and market estimations for conventional and advanced biopsy procedures. The report will also capture key market players that are keenly focusing on innovative biopsy procedures.

SCOPE OF THE REPORT
This research report presents an in–depth analysis of the global biopsy devices marketby device, therapeutic segments and geographic markets. The report includes key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and non–thermal ablation techniques. The report will also discuss the market by type of procedure, such as trends and market estimates of key therapeutic areas such as breast cancer, gastro–intestinal cancer, lung cancer, and cervical cancer, among others. The report will focus on key display technologies used in the process of biopsy such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. The report also reviews the supply chain from manufacturers to surgeons. The report excludes drugs used in the process of biopsy and any device that is used in the cancer treatment process.

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2
STUDY AND OBJECTIVE 2
STUDY BACKGROUND 2
SCOPE OF THE REPORT 2
INTENDED AUDIENCE 3
SOURCE OF INFORMATION AND METHODOLOGY 3
RELATED BCC RESEARCH REPORTS 3
ANALYST'S CREDENTIALS 3
BCC RESEARCH WEBSITE 4
DISCLAIMER 4

CHAPTER 2 EXECUTIVE SUMMARY 6
SUMMARY TABLE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2012-2018
($ MILLIONS) 8

CHAPTER 3 BIOPSY DEVICES MARKET OVERVIEW 10
ROLE OF VACUUM ASSISTED BREAST BIOPSY SYSTEM IN BREAST DISEASE 10
ADVANTAGES OF VAB TECHNIQUE 11
DISADVANTAGES OF VAB TECHNIQUE 11
TRENDS IN LIVER BIOPSY INDICATIONS FOR CHRONIC LIVER DISEASES 11
FACTS OF LIVER DISEASES 12
PERCUTANEOUS LIVER BIOPSY 12
LAPAROSCOPIC SURGERY 12
IMAGING-GUIDED PROSTATE BIOPSY: CONVENTIONAL AND EMERGING
TECHNIQUES 13
TABLE 1 FORECAST PROSTATE CANCER PREVALENCE RATE IN AUSTRALIA,
1998-2020 13
FIGURE 1 FORECAST PROSTATE CANCER PREVALENCE RATE IN AUSTRALIA,
1998-2020 14
TREND IN PROSTATE BIOPSY 15
THE RISK OF SEPSIS 15
FEWER BIOPSIES PROCEDURES 15
CANCER DIAGNOSTICS AND IMAGING MARKETS (MAMMOGRAPHY,
COLONOSCOPY AND ENDOSCOPY) 16
MAMMOGRAPHY 16
COLONOSCOPY 17
ENDOSCOPY 18
REGULATORY SCENARIO FOR BIOPSY DEVICES MARKET 18
REGULATORY ISSUES OF BIOPSY DEVICES IN NORTH AMERICA 18
REGULATORY SCENARIO FOR BREAST BIOPSY IN EUROPEAN UNION 20
TABLE 2 IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY
COUNTRY 21
REIMBURSEMENT SCENARIO 22
REIMBURSEMENT FOR BREAST CANCER SCREENING IN THE U.S. 22
Reimbursement for Breast Reconstruction or Prosthesis 23
The Federal law for Women's Health and Cancer Rights 23
MARKET DYNAMICS 24
DRIVERS 24
Increase in Prevalence for Chronic Diseases 24
Minimally Invasive Procedures as Compared to Other Techniques 24
Raise Public Awareness Level for Diseases Screenings 25
Increase in Aging Population 25
TABLE 3 GLOBAL PERCENTAGE OF AGING POPULATION, 1980-2040 (%) 26
FIGURE 2 GLOBAL PERCENTAGE OF AGING POPULATION, 1980-2040 (%) 26
Strong Reimbursement Policies in Developing Economies 27
Technological Advancement in Imaging Technology 27
RESTRAINTS 27
Increased Competition from Other Cancer Diagnostic Tests 27
High Pricing of Advanced Biopsy Devices 28
Availability of Advance Diagnosis Service 28
OPPORTUNITY/CHALLENGES 29
Tapping Diagnostic Market Present in Emerging Economies 29
TABLE 4 PERCENTAGE OF AGING POPULATION IN DEVELOPING COUNTRIES, 2010
(%) 29
FIGURE 3 PERCENTAGE OF AGING POPULATION IN DEVELOPING COUNTRIES, 2010
(%) 29
CASE STUDIES 30
CASE STUDY 1: BREAST TOMOSYNTHESIS BIOPSY 30
CASE STUDY 2: PET-GUIDED BREAST BIOPSY 30
CASE STUDY 3: BIOPSY USED TO INFILTRATE DUCTAL CARCINOMA. 31

CHAPTER 4 BIOPSY DEVICES MARKET - BY TYPE 33
TABLE 5 GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE THROUGH 2018 ($
MILLIONS) 33
FIGURE 4 GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE 2013 AND 2018 ($
MILLIONS) 33
BREAST BIOPSY DEVICES 34
STEREOTACTIC BIOPSIES 35
ULTRASOUND-GUIDED BIOPSIES 35
SURGICAL OR OPEN BIOPSIES 35
SURGICAL BIOPSIES WITH NEEDLE LOCALIZATION 35
TABLE 6 BREAST CANCER INCIDENCE, PREVALENCE AND MORTALITY, U.S., CHINA
AND INDIA, 2012 36
TABLE 7 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE THROUGH 2018
($ MILLIONS) 36
TABLE 8 TYPES OF BREAST BIOPSY AND MAMOGRAPHY EQUIPMENT 37
TABLE 9 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION THROUGH
2018 ($ MILLIONS) 37
VACUUM-ASSISTED BIOPSY (VAB) DEVICES 37
TABLE 10 GLOBAL MARKET FOR VACUUM ASSISTED BREAST BIOPSY DEVICES BY
REGION THROUGH 2018 ($ MILLIONS) 39
Advantages of VNB technique 39
Disadvantages 39
Capital Equipment 39
Image Guided Breast Biopsies (Ultrasound, Stereotactic/MRI) 40
Ultrasound Guided Breast Core Biopsy 40
Stereotactic/MRI Breast Biopsy (Mammotome) 40
Mammograms 40
Digital Mammography 41
MAGNETIC RESONANCE IMAGING (MRI) 41
The Risks and Benefits of MRI: 42
Disposable Devices 42
VAB Disposable devices 43
Handheld Disposable Devices 43
Disposable Biopsy Punch 43
Punches with Plunger System 43
Punches without Plunger System 43
VAB Markers 44
Advantages of Vacuum Assisted Biopsy (VAB) 44
Disadvantages of Vacuum Assisted Biopsy (VAB) 45
CORE NEEDLE BIOPSY (CNB) 45
TABLE 11 GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 45
Core Needle Biopsy with Stereotactic Mammography 46
Advantages of Core Needle Biopsy 46
Disadvantages of Core Needle Biopsy 46
CNB Disposable Devices 47
Drapes 47
Table Drapes 47
Disposable Magnetic Drapes: 47
Equipment Drape 47
The Source Sleeve 47
Disposable Sterile Kit 48
CNB Markers 48
Advantages of Core Needle Biopsy (CNB) Markers: 49
Disadvantages of Core Needle Biopsy (CNB) Markers: 49
FINE NEEDLE ASPIRATION BIOPSY 49
TABLE 12 GLOBAL MARKET FOR FINE NEEDLE ASPIRATION BIOPSY DEVICES BY
REGION, THROUGH 2018 ($ MILLIONS) 50
GASTROINTESTINAL BIOPSY 50
TABLE 13 GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 51
COLD FORCEPS 51
HOT FORCEPS 51
SOFT TISSUE BIOPSY NEEDLES 52
TABLE 14 GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION,
THROUGH 2018 ($ MILLIONS) 52
CORE NEEDLE BIOPSY NEEDLES 53
FNA (FINE-NEEDLE ASPIRATION) NEEDLES 53
Advantages of FNA needles 54
Disadvantages of FNA needles 54
BRONCHIAL BIOPSY DEVICES 54
TABLE 15 GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 55
FORCEPS 55
Disposable 55
Reusable 56
TBNA NEEDLES 56
Conventional Needles 56
EBUS-TBNA 57
GYNECOLOGICAL BIOPSY DEVICES 57
TABLE 16 GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 58
ENDOMETRIAL SAMPLERS 58
Functions of the Endometrial Samplers 59
ROBOTIC GUIDANCE SYSTEMS 59
TABLE 17 GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION,
THROUGH 2018 ($ MILLIONS) 60
NEUROMATE (RENISHAW) 60
System Benefits of Neuromate 61
Safety Features of Neuromate 61
PATHFINDER (PROSURGICS) 61
INNOMOTION (SYNTHESIS) 62
OTHERS 62
TABLE 18 GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 63
BIOPSY BRUSHES 63
BIOPSY CURETTES 63
TABLE 19 TYPES OF BIOPSY CURETTES 64
BIOPSY PUNCHES 64
TABLE 20 TYPE OF BIOPSY PUNCHES 64

CHAPTER 5 BIOPSY DEVICES MARKET - BY THERAPEUTIC AREAS 66
TABLE 21 GLOBAL BIOPSY MARKET, BY THERAPEUTIC AREA, THROUGH 2018 ($
MILLIONS) 66
FIGURE 5 GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREAS, 2013
AND 2018 ($ MILLIONS) 66
TABLE 22 GLOBAL BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 67
BREAST BIOPSY 67
FNA (FINE NEEDLE ASPIRATION) BIOPSY 68
Fine Needle Aspiration Biopsy for Palpable Growth 68
Guided FNAB for Non-palpable Growth 68
CORE NEEDLE BIOPSY 68
VACUUM-ASSISTED BIOPSIES 69
SURGICAL BIOPSY 69
TABLE 23 GLOBAL BREAST BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 69
GI BIOPSY 69
FNA BIOPSY 70
SURGICAL BIOPSY 70
TABLE 24 GLOBAL GI BIOPSY THERAPEUTIC MARKET BY REGION THROUGH 2018 ($
MILLIONS) 70
PROSTATE BIOPSY 71
LYMPH NODE BIOPSY 71
Laparoscopic biopsy 71
Fine Needle Aspiration Biopsy 71
Surgical Biopsy 72
TABLE 25 GLOBAL PROSTATE BIOPSY THERAPEUTIC MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 72
LIVER BIOPSY 72
LAPAROSCOPIC BIOPSY 73
SURGICAL BIOPSY 73
TABLE 26 GLOBAL LIVER BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 73
LUNG BIOPSY 74
TABLE 27 FIVE-YEAR LUNG CANCER SURVIVAL RATE BY STAGE, 2013 (%) 74
FIGURE 6 LUNG CANCER SURVIVAL RATE BY STAGE, 2013 (%) 74
ADVANTAGES OF LUNG BIOPSY 75
DISADVANTAGES OF LUNG BIOPSY 76
TABLE 28 GLOBAL LIVER BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 76
KIDNEY BIOPSY 76
TABLE 29 INCIDENCE RATE OF KIDNEY CANCER IN U.S., 2013 (NO./%) 76
FIGURE 7 INCIDENCE RATE OF KIDNEY CANCER IN THE U.S., 2013 (%) 76
COMPLICATION OF BIOPSIES TO DETECT KIDNEY DISEASE 77
ADVANTAGES OF RENAL/KIDNEY BIOPSY 78
DISADVANTAGES OF RENAL/KIDNEY BIOPSY 78
TABLE 30 GLOBAL KIDNEY BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 78
GYNECOLOGICAL BIOPSY 79
TABLE 31 PERCENTAGE OF PATIENTS SUFFERING FROM GYNECOLOGICAL CANCER
IN THE UNITED STATES, 2012 (%) 79
FIGURE 8 PERCENTAGE OF PATIENTS SUFFERING FROM GYNECOLOGICAL CANCER
IN THE UNITED STATES, 2012 (%) 79
COMPLICATIONS OF GYNECOLOGY BIOPSY 80
TABLE 32 GLOBAL GYNECOLOGY BIOPSY THERAPEUTIC MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 80
OTHER (PANCREAS, GALLBLADDER AND BILE DUCTS, THYROID, AND OTHERS) 81
PANCREATIC CANCER BIOPSY 81
Type of Biopsy Performed for Pancreatic Cancer Detection 81
Percutaneous Needle Biopsy (PNB) 81
Endoscopic Retrograde Cholangio Pancreatography (ERCP) 82
Endoscopic Ultrasound 82
BILE DUCT CANCER BIOPSY 82
THYROID BIOPSY 82
TABLE 33 GLOBAL OTHER BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 83

CHAPTER 6 BIOPSY DEVICES MARKET- BY DISPLAY TECHNOLOGIES 85
TABLE 34 GLOBAL MARKET FOR BIOPSY DEVICES BY DISPLAY TECHNOLOGIES,
THROUGH 2018 ($ MILLIONS) 85
FIGURE 9 GLOBAL MARKET FOR BIOPSY DEVICES BY DISPLAY TECHNOLOGIES,
2013 AND 2018 ($ MILLIONS) 85
TABLE 35 GLOBAL MARKET FOR BIOPSY DEVICE DISPLAY TECHNOLOGIES BY
REGION, THROUGH 2018 ($ MILLIONS) 87
MRI-GUIDED BREAST BIOPSY 87
ADVANTAGES OF MRI-GUIDED BIOPSY 88
TABLE 36 GLOBAL MARKET FOR MRI GUIDED BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 88
STEREOTACTIC-GUIDED BREAST BIOPSY 89
ADVANTAGES OF STEREOTACTIC GUIDED NEEDLE BIOPSY 90
DISADVANTAGES/LIMITATIONS OF STEREOTACTIC GUIDED NEEDLE BIOPSY 90
TABLE 37 GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES
BY REGION, THROUGH 2018 ($ MILLIONS) 91
ULTRASOUND-GUIDED BIOPSY 91
LIVER BIOPSY 91
THYROID BIOPSY 92
PROSTATE BIOPSY 92
BREAST BIOPSY 92
TRENDS 92
TABLE 38 GLOBAL MARKET FOR ULTRASOUND GUIDED BREAST BIOPSY BY REGION,
THROUGH 2018 ($ MILLIONS) 93
CT (COMPUTED TOMOGRAPHY) 93
ADVANTAGES OF NEEDLE BIOPSY 94
DISADVANTAGES OF NEEDLE BIOPSY 94
LIMITATIONS OF CT GUIDED NEEDLE BIOPSY 94
TABLE 39 GLOBAL MARKET FOR CT GUIDED BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 95
OTHERS 95
TABLE 40 GLOBAL MARKET FOR OTHER BIOPSY DISPLAY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 96

CHAPTER 7 BIOPSY DEVICES: END USER MARKET 98
TABLE 41 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2018 ($
MILLIONS) 98
FIGURE 10 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER 2013 AND 2018
($ MILLIONS) 98
TABLE 42 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER BY REGION,
THROUGH 2018 ($ MILLIONS) 99
DIAGNOSTIC CENTERS 99
TABLE 43 GLOBAL MARKET FOR BIOPSY DEVICES IN DIAGNOSTIC CENTERS, BY
REGION THROUGH 2018 ($ MILLIONS) 100
HOSPITALS 100
TABLE 44 GLOBAL MARKET FOR BIOPSY DEVICES, BY TYPE OF CENTER, THROUGH
2018 ($ MILLIONS) 101
TABLE 45 GLOBAL MARKET FOR BIOPSY DEVICES, IN HOSPITALS, BY REGION,
THROUGH 2018 ($ MILLIONS) 101
SPECIALIZED (CANCER) 101
TABLE 46 GLOBAL MARKET FOR BIOPSY DEVICES, IN SPECIALIZED HOSPITALS BY
REGION THROUGH 2018 ($ MILLIONS) 102
GENERAL 102
TABLE 47 GLOBAL MARKET FOR BIOPSY DEVICES, IN GENERAL HOSPITALS BY
REGION THROUGH 2018 ($ MILLIONS) 103

CHAPTER 8 COMPETITIVE LANDSCAPE 105
FIGURE 11 KEY COMPETITIVE STRATEGIES, 2010-2014 (%) 105
PRODUCT LAUNCH: 106
FIGURE 12 PRODUCT LAUNCH STRATEGY BY COMPANIES, 2010-2014 (%) 106
TABLE 48 LIST OF KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2010-2014 108
PARTNERSHIPS AND COLLABORATIONS: 110
FIGURE 13 PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANY,
2010-2014 (%) 111
TABLE 49 PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANY
2010-2014 112
OTHER STRATEGIES: 113
TABLE 50 PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY 2012
AND 2013 114

CHAPTER 9 BIOPSY DEVICES MARKET: BY REGION 116
TABLE 51 GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH 2018 ($
MILLIONS) 116
FIGURE 14 GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2013 AND 2018 ($
MILLIONS) 116
NORTH AMERICA 117
TABLE 52 GLOBAL MARKET FOR BIOPSY DEVICES IN NORTH AMERICAN REGION,
THROUGH 2018 ($ MILLIONS) 118
EUROPE 118
TRENDS 119
TABLE 53 GLOBAL MARKET FOR BIOPSY DEVICES IN EUROPEAN REGION, THROUGH
2018 ($ MILLIONS) 119
ASIA PACIFIC 119
TABLE 54 GLOBAL MARKET FOR BIOPSY DEVICES IN ASIA-PACIFIC REGION,
THROUGH 2018 ($ MILLIONS) 120
ROW 121
TABLE 55 AGE STANDARDIZED OF INCIDENCE AND MORTALITY RATE, NEW
CASES/DEATHS PER 100,000 WOMEN, 2004 121
FIGURE 15 AGE STANDARDIZED OF INCIDENCE AND MORTALITY RATE, NEW
CASES/DEATHS PER 100,000 WOMEN, 2004 121
TABLE 56 GLOBAL MARKET FOR BIOPSY DEVICES IN REST OF THE WORLD,
THROUGH 2018 ($ MILLIONS) 122

CHAPTER 10 PATENT ANALYSIS 124
FIGURE 16 PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE AND JAPAN
2011-2014 (%) 124
THE U.S. PATENT ANALYSIS BY MARKET PARTICIPANT 124
FIGURE 17 U.S.: PATENT ANALYSIS BY MARKET PARTICIPANT, 2011 THROUGH 2014
(%) 125
EUROPE: PATENT ANALYSIS BY MARKET PARTICIPANT 126
FIGURE 18 EUROPE: PATENT ANALYSIS BY MARKET PARTICIPANT, 2011-2014 (%) 126
JAPAN: PATENT ANALYSIS BY MARKET PARTICIPANTS 126
FIGURE 19 JAPAN: PATENT ANALYSIS BY MARKET PARTICIPANT 2011-2014 (%) 127

CHAPTER 11 COMPANY PROFILES 129
ANGIOTECH PHARMACEUTICALS INC. 129
BIOPSY PRODUCT PORTFOLIO 129
TABLE 57 ANGIOTECH PHARMACEUTICALS, RECENT DEVELOPMENTS 130
BOSTON SCIENTIFIC CORP. 130
BIOPSY PRODUCT PORTFOLIO 130
TABLE 58 BOSTON SCIENTIFIC RECENT DEVELOPMENTS 131
TABLE 59 BOSTON SCIENTIFIC FINANCIALS, 2010-2012 ($ MILLIONS) 131
CARDINAL HEALTH INC. 131
BIOPSY PRODUCT PORTFOLIO 132
TABLE 60 CARDINAL HEALTH INC., RECENT DEVELOPMENTS 132
TABLE 61 CARDINAL HEALTH INC., FINANCIALS, 2011-2013 ($ MILLIONS) 133
CAREFUSION CORP. 133
BIOPSY PRODUCT PORTFOLIO 133
TABLE 62 CAREFUSION CORP. RECENT DEVELOPMENTS 134
TABLE 63 CAREFUSION CORP. FINANCIALS, 2010-2012 ($ MILLIONS) 134
COOK MEDICAL INC. 134
BIOPSY PRODUCT PORTFOLIO 135
TABLE 64 COOK MEDICAL RECENT DEVELOPMENTS 135
C. R. BARD INC. 136
BIOPSY PRODUCT PORTFOLIO 136
TABLE 65 C.R. BARD FINANCIALS, 2010-2012 ($ MILLIONS) 137
DEVICOR MEDICAL PRODUCTS INC. 137
BIOPSY PRODUCT PORTFOLIO 137
TABLE 66 DEVICOR MEDICAL PRODUCT; RECENT DEVELOPMENTS 138
DTR MEDICAL LTD. 138
BIOPSY PRODUCT PORTFOLIO 139
TABLE 67 DTR MEDICAL RECENT DEVELOPMENTS 139
ETHICON ENDO-SURGERY INC. 140
BIOPSY PRODUCT PORTFOLIO 140
TABLE 68 ETHICON ENDO-SURGERY RECENT DEVELOPMENTS 141
TABLE 69 ETHICON ENDO-SURGERY (JOHNSON AND JOHNSON), FINANCIALS,
2010-2012 ($ MILLIONS) 141
FUJIFILM HOLDINGS CORP. 141
BIOPSY PRODUCT PORTFOLIO 141
TABLE 70 FUJIFILM HOLDINGS CORP., RECENT DEVELOPMENTS 142
TABLE 71 FUJIFILM HOLDINGS CORP., 2011-2013 ($ MILLIONS) 142
HOLOGIC INC. 142
BIOPSY PRODUCT PORTFOLIO 143
TABLE 72 HOLOGIC INC., RECENT DEVELOPMENTS 143
TABLE 73 HOLOGIC INC., FINANCIALS, 2010-2012 ($ MILLIONS) 144
INRAD INC. 144
BIOPSY PRODUCT PORTFOLIO 144
INTACT MEDICAL CORP. 144
BIOPSY PRODUCT PORTFOLIO 145
MAUNA KEA TECHNOLOGIES 145
BIOPSY PRODUCT PORTFOLIO 145
TABLE 74 MAUNA KEA TECHNOLOGIES RECENT DEVELOPMENTS 146
TABLE 75 MAUNA KEA TECHNOLOGIES, FINANCIALS, 2010-2012 ($ MILLIONS) 146
MDXHEALTH INC. 146
BIOPSY PRODUCT PORTFOLIO 147
TABLE 76 MDXHEALTH INC., RECENT DEVELOPMENTS 147
MITOMICS INC. 148
BIOPSY PRODUCT PORTFOLIO 148
TABLE 77 MITOMICS INC., RECENT DEVELOPMENTS 149
SANARUS TECHNOLOGIES LLC. 149
BIOPSY PRODUCT PORTFOLIO 150
TABLE 78 SANARUS TECHNOLOGIES LLC. RECENT DEVELOPMENTS 150
UK BIOPSY 150
BIOPSY PRODUCT PORTFOLIO 151
VERAN MEDICAL TECHNOLOGIES 151
BIOPSY PRODUCT PORTFOLIO 151
TABLE 79 VERAN MEDICAL TECHNOLOGIES, RECENT DEVELOPMENTS 152

CHAPTER 12 APPENDIX 154
LIST OF PATENTS NORTH AMERICA 154
LIST OF PATENTS FOR EUROPE 155
LIST OF PATENTS FOR JAPAN 155

LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 7
TABLE 1 FORECAST PROSTATE CANCER PREVALENCE RATE IN AUSTRALIA,
1998-2020 13
TABLE 2 IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY
COUNTRY 21
TABLE 3 GLOBAL PERCENTAGE OF AGING POPULATION, 1980-2040 (%) 26
TABLE 4 PERCENTAGE OF AGING POPULATION IN DEVELOPING COUNTRIES, 2010 (%) 29
TABLE 5 GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE THROUGH 2018 ($
MILLIONS) 33
TABLE 6 BREAST CANCER INCIDENCE, PREVALENCE AND MORTALITY, U.S., CHINA
AND INDIA, 2012 36
TABLE 7 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE THROUGH 2018 ($
MILLIONS) 36
TABLE 8 TYPES OF BREAST BIOPSY AND MAMOGRAPHY EQUIPMENT 37
TABLE 9 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION THROUGH 2018
($ MILLIONS) 37
TABLE 10 GLOBAL MARKET FOR VACUUM ASSISTED BREAST BIOPSY DEVICES BY
REGION THROUGH 2018 ($ MILLIONS) 39
TABLE 11 GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 45
TABLE 12 GLOBAL MARKET FOR FINE NEEDLE ASPIRATION BIOPSY DEVICES BY
REGION, THROUGH 2018 ($ MILLIONS) 50
TABLE 13 GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 51
TABLE 14 GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION,
THROUGH 2018 ($ MILLIONS) 52
TABLE 15 GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 55
TABLE 16 GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 58
TABLE 17 GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION,
THROUGH 2018 ($ MILLIONS) 60
TABLE 18 GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 63
TABLE 19 TYPES OF BIOPSY CURETTES 64
TABLE 20 TYPE OF BIOPSY PUNCHES 64
TABLE 21 GLOBAL BIOPSY MARKET, BY THERAPEUTIC AREA, THROUGH 2018 ($
MILLIONS) 66
TABLE 22 GLOBAL BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 67
TABLE 23 GLOBAL BREAST BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 69
TABLE 24 GLOBAL GI BIOPSY THERAPEUTIC MARKET BY REGION THROUGH 2018 ($
MILLIONS) 70
TABLE 25 GLOBAL PROSTATE BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 72
TABLE 26 GLOBAL LIVER BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH 2018
($ MILLIONS) 73
TABLE 27 FIVE-YEAR LUNG CANCER SURVIVAL RATE BY STAGE, 2013 (%) 74
TABLE 28 GLOBAL LIVER BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH 2018
($ MILLIONS) 76
TABLE 29 INCIDENCE RATE OF KIDNEY CANCER IN U.S., 2013 (NO./%) 76
TABLE 30 GLOBAL KIDNEY BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 78
TABLE 31 PERCENTAGE OF PATIENTS SUFFERING FROM GYNECOLOGICAL CANCER
IN THE UNITED STATES, 2012 (%) 79
TABLE 32 GLOBAL GYNECOLOGY BIOPSY THERAPEUTIC MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 80
TABLE 33 GLOBAL OTHER BIOPSY THERAPEUTIC MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 83
TABLE 34 GLOBAL MARKET FOR BIOPSY DEVICES BY DISPLAY TECHNOLOGIES,
THROUGH 2018 ($ MILLIONS) 85
TABLE 35 GLOBAL MARKET FOR BIOPSY DEVICE DISPLAY TECHNOLOGIES BY REGION,
THROUGH 2018 ($ MILLIONS) 87
TABLE 36 GLOBAL MARKET FOR MRI GUIDED BIOPSY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 88
TABLE 37 GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES
BY REGION, THROUGH 2018 ($ MILLIONS) 91
TABLE 38 GLOBAL MARKET FOR ULTRASOUND GUIDED BREAST BIOPSY BY REGION,
THROUGH 2018 ($ MILLIONS) 93
TABLE 39 GLOBAL MARKET FOR CT GUIDED BIOPSY DEVICES BY REGION, THROUGH
2018 ($ MILLIONS) 95
TABLE 40 GLOBAL MARKET FOR OTHER BIOPSY DISPLAY DEVICES BY REGION,
THROUGH 2018 ($ MILLIONS) 96
TABLE 41 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2018 ($
MILLIONS) 98
TABLE 42 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER BY REGION,
THROUGH 2018 ($ MILLIONS) 99
TABLE 43 GLOBAL MARKET FOR BIOPSY DEVICES IN DIAGNOSTIC CENTERS, BY
REGION THROUGH 2018 ($ MILLIONS) 100
TABLE 44 GLOBAL MARKET FOR BIOPSY DEVICES, BY TYPE OF CENTER, THROUGH
2018 ($ MILLIONS) 101
TABLE 45 GLOBAL MARKET FOR BIOPSY DEVICES, IN HOSPITALS, BY REGION,
THROUGH 2018 ($ MILLIONS) 101
TABLE 46 GLOBAL MARKET FOR BIOPSY DEVICES, IN SPECIALIZED HOSPITALS BY
REGION THROUGH 2018 ($ MILLIONS) 102
TABLE 47 GLOBAL MARKET FOR BIOPSY DEVICES, IN GENERAL HOSPITALS BY
REGION THROUGH 2018 ($ MILLIONS) 103
TABLE 48 LIST OF KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2010-2014 108
TABLE 49 PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANY
2010-2014 112
TABLE 50 PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY 2012
AND 2013 114
TABLE 51 GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH 2018 ($
MILLIONS) 116
TABLE 52 GLOBAL MARKET FOR BIOPSY DEVICES IN NORTH AMERICAN REGION,
THROUGH 2018 ($ MILLIONS) 118
TABLE 53 GLOBAL MARKET FOR BIOPSY DEVICES IN EUROPEAN REGION, THROUGH
2018 ($ MILLIONS) 119
TABLE 54 GLOBAL MARKET FOR BIOPSY DEVICES IN ASIA-PACIFIC REGION,
THROUGH 2018 ($ MILLIONS) 120
TABLE 55 AGE STANDARDIZED OF INCIDENCE AND MORTALITY RATE, NEW
CASES/DEATHS PER 100,000 WOMEN, 2004 121
TABLE 56 GLOBAL MARKET FOR BIOPSY DEVICES IN REST OF THE WORLD,
THROUGH 2018 ($ MILLIONS) 122
TABLE 57 ANGIOTECH PHARMACEUTICALS, RECENT DEVELOPMENTS 130
TABLE 58 BOSTON SCIENTIFIC RECENT DEVELOPMENTS 131
TABLE 59 BOSTON SCIENTIFIC FINANCIALS, 2010-2012 ($ MILLIONS) 131
TABLE 60 CARDINAL HEALTH INC., RECENT DEVELOPMENTS 132
TABLE 61 CARDINAL HEALTH INC., FINANCIALS, 2011-2013 ($ MILLIONS) 133
TABLE 62 CAREFUSION CORP. RECENT DEVELOPMENTS 134
TABLE 63 CAREFUSION CORP. FINANCIALS, 2010-2012 ($ MILLIONS) 134
TABLE 64 COOK MEDICAL RECENT DEVELOPMENTS 135
TABLE 65 C.R. BARD FINANCIALS, 2010-2012 ($ MILLIONS) 137
TABLE 66 DEVICOR MEDICAL PRODUCT; RECENT DEVELOPMENTS 138
TABLE 67 DTR MEDICAL RECENT DEVELOPMENTS 139
TABLE 68 ETHICON ENDO-SURGERY RECENT DEVELOPMENTS 141
TABLE 69 ETHICON ENDO-SURGERY (JOHNSON AND JOHNSON), FINANCIALS,
2010-2012 ($ MILLIONS) 141
TABLE 70 FUJIFILM HOLDINGS CORP., RECENT DEVELOPMENTS 142
TABLE 71 FUJIFILM HOLDINGS CORP., 2011-2013 ($ MILLIONS) 142
TABLE 72 HOLOGIC INC., RECENT DEVELOPMENTS 143
TABLE 73 HOLOGIC INC., FINANCIALS, 2010-2012 ($ MILLIONS) 144
TABLE 74 MAUNA KEA TECHNOLOGIES RECENT DEVELOPMENTS 146
TABLE 75 MAUNA KEA TECHNOLOGIES, FINANCIALS, 2010-2012 ($ MILLIONS) 146
TABLE 76 MDXHEALTH INC., RECENT DEVELOPMENTS 147
TABLE 77 MITOMICS INC., RECENT DEVELOPMENTS 149
TABLE 78 SANARUS TECHNOLOGIES LLC. RECENT DEVELOPMENTS 150
TABLE 79 VERAN MEDICAL TECHNOLOGIES, RECENT DEVELOPMENTS 152

LIST OF FIGURES

SUMMARY FIGURE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2012-2018 ($
MILLIONS) 8
FIGURE 1 FORECAST PROSTATE CANCER PREVALENCE RATE IN AUSTRALIA,
1998-2020 14
FIGURE 2 GLOBAL PERCENTAGE OF AGING POPULATION, 1980-2040 (%) 26
FIGURE 3 PERCENTAGE OF AGING POPULATION IN DEVELOPING COUNTRIES, 2010
(%) 29
FIGURE 4 GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE 2013 AND 2018 ($
MILLIONS) 33
FIGURE 5 GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREAS, 2013
AND 2018 ($ MILLIONS) 66
FIGURE 6 LUNG CANCER SURVIVAL RATE BY STAGE, 2013 (%) 74
FIGURE 7 INCIDENCE RATE OF KIDNEY CANCER IN THE U.S., 2013 (%) 76
FIGURE 8 PERCENTAGE OF PATIENTS SUFFERING FROM GYNECOLOGICAL CANCER IN
THE UNITED STATES, 2012 (%) 79
FIGURE 9 GLOBAL MARKET FOR BIOPSY DEVICES BY DISPLAY TECHNOLOGIES, 2013
AND 2018 ($ MILLIONS) 85
FIGURE 10 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER 2013 AND 2018 ($
MILLIONS) 98
FIGURE 11 KEY COMPETITIVE STRATEGIES, 2010-2014 (%) 105
FIGURE 12 PRODUCT LAUNCH STRATEGY BY COMPANIES, 2010-2014 (%) 106
FIGURE 13 PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANY,
2010-2014 (%) 111
FIGURE 14 GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2013 AND 2018 ($
MILLIONS) 116
FIGURE 15 AGE STANDARDIZED OF INCIDENCE AND MORTALITY RATE, NEW
CASES/DEATHS PER 100,000 WOMEN, 2004 121
FIGURE 16 PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE AND JAPAN
2011-2014 (%) 124
FIGURE 17 U.S.: PATENT ANALYSIS BY MARKET PARTICIPANT, 2011 THROUGH 2014
(%) 125
FIGURE 18 EUROPE: PATENT ANALYSIS BY MARKET PARTICIPANT, 2011-2014 (%) 126
FIGURE 19 JAPAN: PATENT ANALYSIS BY MARKET PARTICIPANT 2011-2014 (%) 127

Read the full report:
Biopsy Devices : Technology and Global Markets

https://www.reportbuyer.com/product/2212013/Biopsy-Devices--Technology-and-Global-Markets.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

10 Orms Street Providence, R.I. 02904
401-453-8000

All content © Copyright 2000 - 2014 WorldNow and WLNE.
All Rights Reserved.

For more information on this site, please read our Privacy Policy and Terms of Service.